However, as with any bioactive compound, some risks and precautions apply
In a series of clinical trials (SURPASS 1-5) individuals with type 2 diabetes have shown reduction in both HbA1c (1.2 to 2.6%) and body weight (5.411.7 kg) (Nauck and D'Alessio 2022)
In the wound, this translates into slower closure, thinner and weaker new tissue, and a higher risk of wound breakdown
Both compounds should be viewed as long-term or potentially lifelong therapies rather than short-term interventions
These outcomes, which include improved collagen organization and faster wound closure, support the hypothesis that antioxidant regulation is a fundamental driver of the peptides regenerative effects
Can Vitamin B12 shots improve mood and mental clarity